Purchase Order SPE2DP17P0228
- Not listed
- This is a $3,178.69 fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Henry Schein, Inc., a Fortune 500 medical and dental supply distributor, for the delivery of lidocaine HCL 2% in 50-count units. The contract has an ultimate completion date of July 23, 2025 and is not set aside for any specific small business designation. Henry Schein, Inc. operates under its Usdg Federal Division to serve various government healthcare customers, including the Department...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Henry Schein, Inc., a global distributor of medical and dental supplies. The contract is for the provision of 4,565,696 units of Lidocaine HCL 2% 50s, a local anesthetic. The contract has a ceiling value of $3,905.00 and is a fixed-price with economic price adjustment type contract. The period of performance runs through September 19, 2024. This contract does not have a set-aside designation, indicating it was...
- This is a fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Henry Schein, Inc., a global medical and dental supply distributor, for the provision of Lidocaine HCL 2% in 50-count packs. The contract has a ceiling value of $3,171.29 and an ultimate completion date of March 13, 2025. This contract award is part of a larger Indefinite Delivery Contract (IDC) held by Henry Schein with the DLA, known as the Electronic Catalog (ECAT) II program, which is valued at...
- This is a delivery order awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Henry Schein, Inc., a global distributor of medical and dental supplies. The award, valued at $4,663.85, is for the delivery of lidocaine hydrochloride 2% in 50-count packages. The delivery order is a fixed-price contract with economic price adjustment, with a completion date of November 21, 2024. The contract does not have a set-aside designation, indicating it was competed on a full...
- The U.S. Defense Logistics Agency awarded a $1,228.45 fixed-price delivery order contract to Henry Schein, Inc., a global medical and dental supply distributor, for the provision of 4564551764 Lidocaine HCL 2% 50s. This order is under Henry Schein's existing Indefinite Delivery Vehicle (IDV) contracts, including a $51,896.98 Department of Veterans Affairs (VA) Blanket Purchase Agreement (BPA) for denture teeth and a $1,091,005 Indian Health Service BPA for dental supplies. The contract has a...
- This is a $1,055.60 fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Henry Schein, Inc. for the delivery of lidocaine HCL 2% in 50 count packages. The contract has a period of performance from May 14, 2024 to May 28, 2024 and does not have a set-aside designation, indicating it was competed on a full and open basis. Henry Schein, Inc., a global medical and dental supply distributor, has an extensive history of federal contract awards and subcontracts with...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Henry Schein, Inc., a Fortune 500 global medical and dental supply distributor based in Melville, New York. The $2,811.60 fixed-price delivery order contract is for the supply of LIDOCAINE HCL 2% 50S, with an ultimate completion date of June 24, 2025. Henry Schein's Usdg Federal Division holds a $234.3 million Indefinite Delivery Contract (IDC) with the DLA's Electronic Catalog (ECAT) II program, which covers a...
- This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to Henry Schein, Inc. The contract, valued at $3,336.82, is for the delivery of Lidocaine HCL 2% medication in quantities of 50. This award is not associated with a set-aside program and represents full and open competition. Henry Schein, Inc. is a global distributor of medical and dental supplies, and this contract is part of the company's Enterprise Health / Federal Sales Division. The company has a long history of...
- Henry Schein, Inc.'s USDG Federal Division was awarded a delivery order on September 9, 2025, for the supply of Lidocaine HCL 2% in 50-unit quantities to the Defense Logistics Agency's Medical Supply Chain. This fixed-price delivery order with economic price adjustment carries a ceiling value of $3,497.26 and an ultimate completion date of September 23, 2025. The contract utilizes no set-aside designation and represents performance to be fulfilled at the contractor's location in Huntington...
- The U.S. Defense Logistics Agency (DLA) awarded a $1,488.34 Delivery Order contract to Henry Schein, Inc. Enterprise Health / Federal Sales Division for the supply of 4564459775 - LIDOCAINE HCL 2% 50S. This product is a local anesthetic pharmaceutical. The contract does not have a set-aside designation, indicating that Henry Schein competed in full and open competition. Henry Schein is a global medical and dental supply distributor that has an extensive history of providing a wide range of...
This is a firm fixed-price purchase order awarded by the Defense Logistics Agency (DLA) to Henry Schein, Inc., a Fortune 500 medical and dental supply distributor, for the delivery of Lidocaine Hydrochloride, a local anesthetic. The contract has a ceiling value of $4,405.96 and an ultimate completion date of February 13, 2017. The award is not associated with a set-aside program and was competed on a full and open basis. Henry Schein, Inc. operates through its Usdg Federal Division to serve various government healthcare agencies, including the Department of Defense, with a wide range of medical and dental supplies. The company also holds a $234.3 million Indefinite Delivery Contract (IDC) with the DLA's Electronic Catalog (ECAT) II program for a broader range of dental products and consumables.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.4k | 1/11/17 |